Press Releases

Date Title View
Toggle Summary MD+DI, the Global MedTech Industry Authority, Announces the 2013 Medical Device Manufacturer of the Year View HTML
Toggle Summary NHS England to consider reimbursing “bionic eye” treatment for blindness caused by retinitis pigmentosa View HTML
Toggle Summary CMS Approves New Technology Add-on Payment and Pass-Through Payment for the Argus® II Retinal Prosthesis System
Payments May Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings
View HTML
Toggle Summary Second Sight Medical Products Receives FDA Approval for Argus II System
Argus® II Retinal Prosthesis System is the first approved bionic eye in the US with life-changing potential for the treatment of blindness due to retinitis pigmentosa
View HTML
Toggle Summary FDA Panel Recommends FDA Approval for Second Sight’s Argus® II Retinal Prosthesis System View HTML
Toggle Summary Results from International Trial of Second Sight’s Argus® II Retinal Prosthesis System Published in Ophthalmology View HTML
Toggle Summary Second Sight announces First Commercial Implant of Retinal Prosthesis View HTML
Toggle Summary Second Sight wins 2011 World Technology Award View HTML
Toggle Summary Second Sight announces that Argus II is now available in Germany View HTML
Toggle Summary Second Sight Announces Significant Results from the Argus™ II Retina Prosthesis Trial at the ARVO 2011 Annual Meeting View HTML